PhUSE SDE - Beerse, Belgium



Theme & Description:

The Single Day Event in Beerse was another great PhUSE event with over 50 people attending.
The main focus of this year’s EU SDEs is put on data transparency and submission standards in the pharmaceutical industry.


Click on the links below to download the presentations, photos and brochure.


Moving to Define.xml V2.0.0, Davy Baele (Business & Decision Life Sciences)

Improving Transparency of Clinical data using analytics, Mark Lambrecht (SAS)

Creating patient treatment journeys based on outpatient pharmacy data using an extended macro toolbox, Berber Snoeijer (PHARMO Institute)

Underpinning the underpinning of CDISC - Using the Operational Data Model, Geoff Low (Medidata Solutions Worldwide)

New Working Group on Emerging Technologies: update from the first meeting in Washingstn DC and starting projects - informal communication, Isabelle de Zegher (Parexel International)

The off shoring and outsourcing of R&D and innovation activities in the Pharmaceutical Industry, Mark Bynens (LACO N.V.)

Identifying atypical sites with central statistical monitoring, Erik Doffagne (CluePoints)

Skills for SAS® Programmers in Epidemiology, Phil Holland (Holland Numerics)

Best Practices for R Deployment in Pharma, Tobias Verbeke (Open Analytics)













How do I join the PhUSE Society?

There are two easy ways to join PhUSE:

1. Click through to the on-line registration website by clicking here.

2. Contact for multiple membership applications or for invoicing arrangements.



PhUSE US Computational Science Symposium 2017

The PhUSE Computational Science Symposium (CSS) will be celebrating its 6th annual event in 2017, having established itself as the premier collaboration within the clinical trial environment. The collaboration has continued to grow, hosting its inaugural event in Europe during 2016 and engaging other regulatory agencies including the EMA and PMDA.

This year's event will once again be co-sponsored by the FDA and PhUSE and will bring together academia, regulators, industry and technology providers to address computational science needs in support of regulatory review.

Find Out More